Authors: Bested, Kirsten et al PAIN Reports 8(4):p e1080, July/August 2023. Introduction: Fibromyalgia (FM) is a chronic fluctuating, nociplastic pain condition. Naltrexone is a µ-opioid-receptor antagonist; preliminary studies have indicated a pain-relieving effect of low-dose naltrexone (LDN) in patients with FM. The impetus for studying LDN is the assumption of analgesic efficacy and thus reduction of […]
Read MoreAuthor: Christopher Medrano , MD KevinMD.com If you’ve experienced a migraine headache before, the sensation is often very distinct: throbbing pain, sensitivity to light and loud noise, and sometimes nausea and vomiting. Migraine symptoms can be uncomfortable and distressing. Equally concerning is when a migraine sufferer recognizes these symptoms in their child. Migraines typically emerge […]
Read MoreAUTHORS: Jaramillo, Sebastian MD et al Anesthesia & Analgesia 138(1):p 141-151, January 2024. BACKGROUND: Hemoglobin concentration ([Hb]) in the perioperative setting should be interpreted in the context of the variables and processes that may affect it to differentiate the dilution effects caused by changes in intravascular volume. However, it is unclear what variables and processes affect […]
Read MoreAuthor: Rita Astani, Coronis Anesthesia Summary Heart cases involve lots of base units and lots of time units, but how much value do they really bring to an anesthesia practice? Today’s article examines the current volume and relative value of cardiac anesthesia cases. There was a time, not too long ago, when cardiovascular anesthesiologists were […]
Read MoreAUTHORS: Shaefi, Shahzad MD, MPH et al Anesthesia & Analgesia 136(2):p 295-307, February 2023. BACKGROUND: Despite the growing contributions of critical care anesthesiologists to clinical practice, research, and administrative leadership of intensive care units (ICUs), relatively little is known about the subspecialty-specific clinical practice environment. An understanding of contemporary clinical practice is essential to recognize the […]
Read More